We are live on ! Find out more
KLWA

Kelly Lawrence W & Associates Portfolio holdings

AUM $360M
1-Year Est. Return 16.9%
This Fund
S&P 500
This Quarter Est. Return
+14.36%
1 Year Est. Return
+16.9%
3 Year Est. Return
+58.93%
5 Year Est. Return
+78.96%
10 Year Est. Return
+418.66%
AUM
$417M
AUM Growth
+$44.2M
Cap. Flow
-$3.95M
Cap. Flow %
-0.95%
Top 10 Hldgs %
45.65%
Holding
174
New
10
Increased
20
Reduced
37
Closed
2

Top Buys

Rank Stock Value
1
CSGP icon
CoStar Group
CSGP
+$11.3M
2
OKE icon
Oneok
OKE
+$855K
3
AMT icon
American Tower
AMT
+$830K
4
PYPL icon
PayPal
PYPL
+$544K
5
COF icon
Capital One
COF
+$408K

Sector Composition

Rank Sector Weight
1 Technology 32.66%
2 Financials 12.81%
3 Healthcare 12.24%
4 Communication Services 12.12%
5 Consumer Staples 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AMAT icon
26
Applied Materials
AMAT
$417B
$5.68M 1.36%
35,038
-830
-2% -$122K
AFL icon
27
Aflac
AFL
$60.7B
$4.57M 1.1%
55,415
-500
-0.9% -$40.3K
CSCO icon
28
Cisco
CSCO
$475B
$3.48M 0.83%
68,858
PG icon
29
Procter & Gamble
PG
$338B
$3.45M 0.83%
23,520
-1,709
-7% -$253K
CVX icon
30
Chevron
CVX
$386B
$3.01M 0.72%
20,194
-1,063
-5% -$161K
MSFT icon
31
Microsoft
MSFT
$3.74T
$3M 0.72%
7,965
-160
-2% -$56.9K
WWD icon
32
Woodward
WWD
$21.1B
$2.97M 0.71%
21,830
HXL icon
33
Hexcel
HXL
$7.6B
$2.92M 0.7%
39,559
-1,800
-4% -$122K
CRM icon
34
Salesforce
CRM
$162B
$2.76M 0.66%
10,475
JPM icon
35
JPMorgan Chase
JPM
$962B
$2.02M 0.48%
11,866
-60
-0.5% -$9.09K
ABBV icon
36
AbbVie
ABBV
$442B
$1.7M 0.41%
10,951
RITM.PRB icon
37
Rithm Capital Corp 7.125% Series B Preferred Stock
RITM.PRB
$284M
$1.63M 0.39%
69,716
SHEL icon
38
Shell
SHEL
$250B
$1.34M 0.32%
20,423
-2,000
-9% -$131K
WFC.PRL icon
39
Wells Fargo 7.5% Non Cumv Perp Conv
WFC.PRL
$4.66B
$1.18M 0.28%
987
SCHW
40
Charles Schwab
SCHW
$186B
$1.17M 0.28%
17,043
-25
-0.1% -$1.44K
OKE icon
41
Oneok
OKE
$57.7B
$1.17M 0.28%
16,593
+12,750
+332% +$855K
VRSN icon
42
VeriSign
VRSN
$26B
$1.03M 0.25%
4,995
EW icon
43
Edwards Lifesciences
EW
$54B
$1.01M 0.24%
13,250
GILD icon
44
Gilead Sciences
GILD
$168B
$894K 0.21%
11,031
DOW icon
45
Dow Inc
DOW
$22.6B
$779K 0.19%
14,199
AGNCO icon
46
AGNC Investment Dep Shares 1/1000 Cumulative Series E
AGNCO
$756K 0.18%
32,634
+1,100
+3% +$25.2K
ROST icon
47
Ross Stores
ROST
$80.8B
$692K 0.17%
5,000
AVY icon
48
Avery Dennison
AVY
$13.6B
$667K 0.16%
3,300
ABT icon
49
Abbott
ABT
$190B
$667K 0.16%
6,060
T.PRA icon
50
AT&T Series A
T.PRA
$859M
$624K 0.15%
29,300

Similar funds

Kelly Lawrence W & Associates's Q4 2023 Portfolio in Review

As of Q4 2023, Kelly Lawrence W & Associates held 174 positions worth $417M, up 12% from $373M the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Kelly Lawrence W & Associates's Q4 2023 filing shows 10 new, 20 increased, 37 reduced and 2 closed positions. Its largest new stake was CoStar Group: 139,245 shares worth $12.2M. The largest sale was Check Point Software Technologies, an estimated $14.6M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.

  • Kelly Lawrence W & Associates's largest Q4 2023 buy was CoStar Group: 139,245 shares worth $12.2M.
  • Kelly Lawrence W & Associates added most to Oneok in Q4 2023, an estimated $855K increase.
  • Kelly Lawrence W & Associates's biggest Q4 2023 reduction was Check Point Software Technologies, cutting an estimated $14.6M.
  • Kelly Lawrence W & Associates fully exited Emerson Electric in Q4 2023, selling an estimated $24.1K.
  • Kelly Lawrence W & Associates's ten largest holdings make up 46% of its $417M portfolio in Q4 2023.
  • Kelly Lawrence W & Associates opened 10 new positions and closed 2 in Q4 2023.
  • Kelly Lawrence W & Associates's portfolio value rose 12% quarter-over-quarter to $417M.

Based on Kelly Lawrence W & Associates's 13F filing for Q4 2023, filed 14 Feb 2024.